
IntraBio Inc. Secures Orphan Medicinal Product Designation for CACNA1A Disorders
Positive Opinion Paves Way for Phase III Trial of Acetylleucine in Rare Neurological Conditions Why are rare neurological disorders often overlooked in drug development? IntraBio Inc., an Austin, Texas-based global…












